XBIT MEXC RealStocks
Own real XBIT shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-17 06:06:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
XBiotech Inc. (XBIT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.85, with a market capitalization of $59.76M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.80 to $2.73. This page covers its latest market performance, valuation, price trends and company information.
$59.76M | |
$1.97 | |
$2.01 | |
$1.81 | |
$1.96 | |
108.46K | |
60.83K | |
-- | |
$2.73 | |
$1.80 | |
-- | |
-- |
XBiotech Inc. (XBIT) last closed at $1.85 as of 2026-11-17 00:22:00, down 5.10% ($0.10) from the previous close of $1.96.
During the latest regular trading session, XBIT traded between $1.81 and $2.01, with a volume of 108.46K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, XBiotech Inc. (XBIT) moved from $1.87 to $1.85, representing a decline of 1.07% ($0.02).
The stock traded between $1.81 and $2.01 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 38.45 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 5.4%
XBIT is currently trading at $1.85, placing it 5.4% of the way from its 52-week low of $1.80 to its 52-week high of $2.73. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 87 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for XBiotech Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | Jul 15, 2021 |
| Payment Date | Jul 23, 2021 |
| Dividend Per Share | $2.0995 |
Eligible investors can buy real shares of XBiotech Inc. (XBIT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to XBIT, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between XBIT shares and USD.
XBIT Shares to USD
1.00 XBIT shares = 1.85 USD
Calculations are estimates based on the latest available price and are for reference only.